Mustang Bio (MBIO) Other financing activities (2018 - 2025)

Mustang Bio (MBIO) has reported Other financing activities for 7 consecutive years, with $7.1 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $7.1 million in Q3 2025; TTM through Dec 2025 was $7.1 million, a 102.81% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, up 102.81% from the prior year.
• Other financing activities was $7.1 million for Q3 2025 at Mustang Bio, up from $3.5 million in the prior quarter.
• Over five years, Other financing activities peaked at $7.1 million in Q3 2025 and troughed at $48000.0 in Q1 2024.
• A 5-year average of $1.3 million and a median of $116000.0 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities sank 40.4% in 2022 and changed 0.0% in 2023, its largest moves.
• Over 5 years, Other financing activities stood at $151000.0 in 2021, then sank by 40.4% to $90000.0 in 2022, then changed by 0.0% to $90000.0 in 2023, then jumped by 3761.11% to $3.5 million in 2024, then jumped by 105.61% to $7.1 million in 2025.
• The last three Other financing activities figures came in at $7.1 million (Q3 2025), $3.5 million (Q4 2024), and $48000.0 (Q1 2024), per Business Quant data.